Casting and Mechanized Titanium Restorations

INTRODUCTION: New materials and methods for clinical dentistry are continuously being introduced. There is a growing interest in the use of titanium as a restorative material for several reasons: its relatively low cost, favorable physical properties and biocompatibility. However, titanium is technically more difficult to handle than conventional metal alloys. There are two fabrication methods for titanium restorations: casting and mechanized (a combination of machine duplication and spark erosion-Pro- -cera method). PURPOSE: The aim of this review was to evaluate the advantages and disadvantages of the two fabrication methods used for titanium restorations and to make some recommendations on the indications. MATERIAL AND METHODS: Dental literature was reviewed including clinical and technique articles on the use of titanium in prosthodontic restorations. RESULT: The use of mechanized titanium has more restrictive indications than casting, but assures better marginal fit of the restorations. The bond strength of porcelain fused to titanium is questioned, because of the lower rigidity of titanium than conventional alloys and discrepancies in the thermal expansion coefficient between titanium and ceramic. Thus, low fusing ceramics tend to predominate today. The esthetic result varies. Furthermore titanium restorations require a qualified dental technician. CONCLUSION: It can be concluded that titanium is a promising alternative for prosthodontic restorations. Several error sources associated with casting can be eliminated with mechanized titanium restorations. However, little information is availableon the clinical performance of titanium restorations. More clinical prospective studies are necessary before titanium can be recommended for general clinical use

Three-Year Clinical Evaluation of in Ceram Zirconia Bridges.

INTRODUCTION: The demand for esthetic restorations has led to the development of materials that are metal free. These materials must have adequate strength to be an alternative for the fabrication of fixed partial dentures in posterior segments of the dental arches. PURPOSE: The aim of the present study was to investigate in a long-term perspective whether the strength of the In Ceram Zirconia material is sufficient for use in posterior bridges. MATERIAL AND METHODS: Sixteen patients, who were between 23 and 50 years of age, with indications for a fixed denture replacing premolar or molar, were examined for participation in the study. Eighteen bridges were constructed with one or two pontics and two abutments, one on each side of the pontic. The patients were informed about risks of, and alternatives to, the proposed therapy. The supporting teeth were prepared with chamfer finish line and lack ofsharp line angles. Impressions were made with a rigid standard tray with an A-silicone putty soft and light-body materials (Aquasil, Dentsply). The laboratory procedures were performed by a laboratory autho rised by the Vita supplier. Ten of the bridges were cemented permanently with zinc phosphate cement and eight with glass ionomer cement. Clinical evaluation of the bridges were performed according to the California Dental Association’s quality evaluation system. RESULT: After three year evaluation all eighteen bridges were without signs of or any change in colour, and marginal integrity. CONCLUSION: In Ceram Zirconia is a potential alternative for full ceramic bridges in the posterior segments

Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer

BACKGROUND: The clinical benefit of determining the status of HER-2/neu amplification in breast cancer patients is well accepted. Although immunohistochemistry (IHC) is the most frequently used method to assess the over-expression of HER-2 protein, fluorescent in-situ hybridization (FISH) is recognized as the "gold standard" for the determining of HER-2/neu status. The greatest discordance between the two methods occurs among breast tumors that receive an indeterminate IHC score of 2+. More recently, a real-time polymerase chain reaction (PCR) assay using the LightCycler(® )has been developed for quantifying HER-2/neu gene amplification. In this study, we evaluated the sensitivity and specificity of a commercially available LightCycler assay as it compares to FISH. To determine whether this assay provides an accurate alternative for the determination of HER-2/neu status, we focused primarily on tumors that were deemed indeterminate or borderline status by IHC. METHODS: Thirty-nine breast tumors receiving an IHC score of 2+ were evaluated by both FISH and LightCycler(® )technologies in order to determine whether quantitative real-time PCR provides an accurate alternative for the determination of HER-2/neu status. RESULTS: We found a high concordance (92%) between FISH and real-time PCR results. We also observed that 10% of these tumors were positive for gene amplification by both FISH and real-time PCR. CONCLUSION: The data show that the results obtained for the gene amplification of HER-2/neu by real-time PCR on the LightCycler(® )instrument is comparable to results obtained by FISH. These results therefore suggest that real-time PCR analysis, using the LightCycler(®), is a viable alternative to FISH for reassessing breast tumors which receive an IHC score of 2+, and that a combined IHC and real-time PCR approach for the determination of HER-2 status in breast cancer patients may be an effective and efficient strategy

Essential role of proteasomes in maintaining self-renewal in neural progenitor cells

Protein turnover and homeostasis are regulated by the proteasomal system, which is critical for cell function and viability. Pluripotency of stem cells also relies on normal proteasomal activity that mitigates senescent phenotypes induced by intensive cell replications, as previously demonstrated in human bone marrow stromal cells. In this study, we investigated the role of proteasomes in self-renewal of neural progenitor cells (NPCs). Through both in vivo and in vitro analyses, we found that the expression of proteasomes was progressively decreased during aging. Likewise, proliferation and self-renewal of NPCs were also impaired in aged mice, suggesting that the down-regulation of proteasomes might be responsible for this senescent phenotype. Lowering proteasomal activity by loss-of-function manipulations mimicked the senescence of NPCs both in vitro and in vivo; conversely, enhancing proteasomal activity restored and improved self-renewal in aged NPCs. These results collectively indicate that proteasomes work as a key regulator in promoting self-renewal of NPCs. This potentially provides a promising therapeutic target for age-dependent neurodegenerative diseases

Induction of HIF-1 alpha by HIV-1 Infection in CD4(+) T Cells Promotes Viral Replication and Drives Extracellular Vesicle-Mediated Inflammation

Chronic immune activation and inflammation are hallmarks of HIV-1 infection and a major cause of serious non-AIDS events in HIV-1-infected individuals on antiretroviral treatment (ART). Herein, we show that cytosolic double-stranded DNA (dsDNA) generated in infected CD4+ T cells during the HIV-1 replication cycle promotes the mitochondrial reactive oxygen species (ROS)-dependent stabilization of the transcription factor hypoxia-inducible factor 1α (HIF-1α), which in turn, enhances viral replication. Furthermore, we show that induction of HIF-1α promotes the release of extracellular vesicles (EVs). These EVs foster inflammation by inducing the secretion of gamma interferon by bystander CD4+ T cells and secretion of interleukin 6 (IL-6) and IL-1β by bystander macrophages through an HIF-1α-dependent pathway. Remarkably, EVs obtained from plasma samples from HIV-1-infected individuals also induced HIF-1α activity and inflammation. Overall, this study demonstrates that HIF-1α plays a crucial role in HIV-1 pathogenesis by promoting viral replication and the release of EVs that orchestrate lymphocyte- and macrophage-mediated inflammatory responses.IMPORTANCE Human immunodeficiency virus type 1 (HIV-1) is a very important global pathogen that preferentially targets CD4+ T cells and causes acquired immunodeficiency syndrome (AIDS) if left untreated. Although antiretroviral treatment efficiently suppresses viremia, markers of immune activation and inflammation remain higher in HIV-1-infected patients than in uninfected individuals. The hypoxia-inducible factor 1α (HIF-1α) is a transcription factor that plays a fundamental role in coordinating cellular metabolism and function. Here we show that HIV-1 infection induces HIF-1α activity and that this transcription factor upholds HIV-1 replication. Moreover, we demonstrate that HIF-1α plays a key role in HIV-1-associated inflammation by promoting the release of extracellular vesicles which, in turn, trigger the secretion of inflammatory mediators by noninfected bystander lymphocytes and macrophages. In summary, we identify that the coordinated actions of HIF-1α and extracellular vesicles promote viral replication and inflammation, thus contributing to HIV-1 pathogenesis